Identifying microRNAs as biomarkers of drug resistance in Multiple Myeloma patients: a pilot project to contribute to guiding personalized therapeutic decisions”
Team
Sponsor
APCL
Dates and Lifetime
From: 2017-08-08 To: 2020-12-31
Duration: 41 months
Reference
APCL/SPH/AMGEN
Code
RBMM2